US Patent Issued to Bio-Techne on Aug. 11 for "Anti-severe acute respiratory syndrome coronavirus antibodies" (Minnesota, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,704,517, issued on Aug. 11, was assigned to Bio-Techne Corp. (Minneapolis).

"Anti-severe acute respiratory syndrome coronavirus antibodies" was invented by Christine Andrea Goetz (Blaine, Minn.), Jody Bonnevier (Chanhassen, Minn.), Christopher David Hammerbeck (Shoreview, Minn.), Ernesto Rubin Resnik (Minneapolis), Cyrus B. Munshi (Blaine, Minn.) and Enqing Tan (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-SARS-CoV-specific monoclonal antibodies, methods of making and characterizing those antibodies, and methods of using those antibodies are described herein. In some embodiments, the antibodies may bind to both SARS-CoV-1 and SAR...